|
Volume 272, Number 49, Issue of December 5, 1997
pp. 31149-31155
COUP-TF and Sp1 Interact and Cooperate in the Transcriptional
Activation of the Human Immunodeficiency Virus Type 1 Long Terminal
Repeat in Human Microglial Cells*
(Received for publication, August 4, 1997, and in revised form, September 22, 1997)
Olivier
Rohr
,
Dominique
Aunis
and
Evelyne
Schaeffer
§
From Unité 338 INSERM, 5 rue Blaise Pascal,
67084 Strasbourg Cedex, France
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
FOOTNOTES
ACKNOWLEDGEMENTS
REFERENCES
ABSTRACT
We have recently reported that chicken ovalbumin
upstream promoter transcription factor (COUP-TF) activates human
immunodeficiency virus type 1 (HIV-1) gene transcription in glial and
neuronal cells. Here, we have examined the role of COUP-TF in
microglial cells, the major target cells for HIV-1 infection in brain.
We show that COUP-TF activates gene expression from both the
lymphotropic LAI and the macrophage-tropic JR-FL HIV-1 strains.
Although COUP-TF binds to the 352/ 320 nuclear receptor responsive
element of the long terminal repeat, it functions as a transcriptional
activator by acting on the 68/+29 minimal promoter. This region is a
direct target of transcription factors Sp1 and Sp3. We report the
discovery and features of a physical and functional interplay between
COUP-TF and Sp1. Our cotransfection experiments provide evidence for a functional synergism between Sp1 and COUP-TF leading to enhanced transcriptional activity of the HIV-1 long terminal repeat through the
Sp1 element. In contrast, Sp3 functions as a repressor of Sp1- or
COUP-TF-induced activation. We further demonstrate that COUP-TF and Sp1
are capable of physically interacting, via the DNA-binding domain of
COUP-TF, in vitro and in the cell. These findings reveal
how the novel interplay of Sp1 and COUP-TF families of transcription
factors regulate HIV-1 gene expression.
INTRODUCTION
Human immunodeficiency virus type 1 (HIV-1)1 infects the central
nervous system (CNS) and plays a direct role in the pathogenesis of
AIDS dementia (1, 2), but how the infection leads to brain damage has
been poorly understood. The CNS resident macrophages or microglial
cells (3) are the primary target of HIV-1 infection in brain (4-7).
Glial and neuronal cells are capable of harboring a restricted
infection with HIV-1 (8-10). HIV-1 infection is established in the CNS
by viruses present early in infection (11). Macrophage-tropic isolates
infect microglial cells more efficiently then do T cell tropic isolates
and predominate early in the infection (12). Therefore we have
performed our studies with the macrophage-tropic JR-FL strain, compared
with the T-tropic LAI strain.
HIV-1 gene expression is controlled by a combination of viral and host
cell transcription factors interacting with the long terminal repeat
(LTR) region (for review, see Refs. 13 and 14). Recent studies have
focused on transcription factors that regulate HIV-1 expression in
brain cells. Analysis of HIV-1 directed gene expression in transgenic
mice derived from CNS-isolated HIV-1 strains (15), suggests that HIV-1
replication in the CNS uses transcription factors different from those
in non-neural tissues (16-18). Transcriptional activity of the HIV-1
promoter is mediated by B regulatory sequences of the LTR, through
the action of the transcription factor NF- B, both in neurons (19,
20) and in astrocytes (21). Besides the B regulatory element, our
recent data have highlighted the importance of the nuclear
receptor-responsive element (NRRE), which appears to be the point of
convergence of a network of physiological signals which modulate HIV-1
gene expression in brain cells. We have described that the orphan
nuclear receptors COUP-TF/Ear3 (22-24) are present in three human
brain cell lines, oligodendroglioma TC-620, astrocytoma U373-MG, and
neuroblastoma SK-N-MC cells. Our data have also demonstrated the
importance of COUP-TF as a potent transcriptional activator in
oligodendroglioma cells, of both the lymphotropic LAI and the
neurotropic JR-CSF HIV-1 LTR. They revealed the action of the dopamine
transduction pathway, which coupled to COUP-TF, contributes to enhance
HIV-1 gene transcription in neuronal cells (25). Our findings have further established the importance of the retinoic acid signaling pathway in HIV-1 gene transcription in glial and neuronal cells (26).
Except for retinoid receptors, the role of transcription factors
belonging to the steroid/thyroid/retinoid receptor superfamily has not
yet been described in microglial cells.
In this report, we have investigated the functional effect and the
molecular mechanisms by which the orphan nuclear receptor COUP-TF
regulates HIV-1 gene expression in a human microglial cell line (27).
Our findings reveal the importance of COUP-TF as an activator of
LTR-driven transcription of both the T cell line-tropic LAI and the
macrophage-tropic JR-FL HIV-1 strains. We provide evidence for a novel
physiological and functional interaction between the DNA-binding domain
of COUP-TF and the transcription factor Sp1, leading to enhanced
transactivation of the HIV-1 LTR. In addition, our data reveal that the
COUP-TF- and Sp1-induced stimulation is repressed by the transcription
factor Sp3. These data describe novel molecular mechanisms which govern
the network of interactions between the HIV-1 LTR, the transcriptional
activators COUP-TF and Sp1, and the repressor Sp3, in the regulation of
HIV-1 gene expression.
MATERIALS AND METHODS
Plasmids Constructs
The LTR(JR-FL)-CAT and LTR(LAI)-CAT
vectors were described previously (25, 26, 28). The 68/+80 and
40/+80 LTR-CAT vectors were constructed by subcloning into the
SmaI site of pUC19-CAT0 the
HaeIII-HindIII and
DdeI-HindIII blunt-ended LTR insert,
respectively, isolated from 489/+80 LTR(LAI)-CAT.
To construct the GST-COUP-1 vector, the plasmid RSV-COUP-TF (gift of
Dr. M. J. Tsai, Houston, TX) was digested with SmaI and EcoRI and the COUP-TF insert was subcloned in-frame with the
GST-encoding sequences into the SmaI and EcoRI
sites of pGEX2T. To construct GST-COUP-2 and GST-COUP-3, the
SmaI-SalI and SmaI-XmnI
COUP-TF fragments were isolated from the RSV-COUP vector, blunt-ended, and inserted into the SmaI site of pGEX2T. The Sp1 cDNA
was excised with XbaI and EcoRI from the
pEVR2-Sp1 vector (gift of Dr. G. Suske, Marburg, Germany) and religated
into the XbaI and EcoRI sites of pBluescript
KS . To construct pRSV-COUP-TF, COUPdel308, and
COUPdel148, the EcoRI-EcoRI, EcoRI-SalI, and EcoRI-XmnI
fragments were isolated from RSV-COUP-TF, blunt-ended, and inserted in
the blunt-ended NotI site of pRc/RSV (Invitrogen).
Cell Culture, Transfections, and CAT Assays
Human
microglial cells (27) were grown in Dulbecco's modified Eagle's
medium supplemented with 10% fetal calf serum and 10 mM
HEPES in the presence of penicillin-streptomycin (100 units/ml). Cells
(106) were transfected by the calcium phosphate
precipitation method as described previously (29) with either 1 pmol of
plasmid reporter DNA or cotransfected with reporter DNA (1 pmol) and
the indicated expression vector: RSV-COUP-TF (0.2 pmol; gift of Dr.
M. J. Tsai; Houston, TX), CMV-Sp1 (0.2 or 0.5 pmol as indicated;
gift of Dr. R. Tjian, Berkeley, CA), pRc/CMV-Sp3 (0.2 or 0.5 pmol as
indicated; gift of Dr. G. Suske, Marburg, Germany). Each transfection
was done in duplicate and repeated a minimum of three separate times with at least two different plasmid preparations. Cell extracts were
prepared 48 h after transfection. CAT assays were performed as
described previously (29). Reaction mixtures containing 15 µg of
protein were incubated at 37 °C for 2 h.
Electrophoretic Mobility Shift Assays
EMSAs were performed
with nuclear proteins as described previously (25). Pure Sp1 protein (2 footprint units, Promega) was used in the presence of 3 µg of bovine
serum albumin. Mixtures were incubated for 15 min at 4 °C and
protein-DNA complexes were analyzed by electrophoresis on a 4 or 6%
polyacrylamide gel in 0.25 × TBE. For supershift assays,
antibodies directed against COUP-TF (gift of Dr. M. J. Tsai) or
against Sp1 or Sp3 (Santa Cruz Biotechnology) or against T3R (gift of
Dr. P. Chambon, Strasbourg, France) or normal rabbit serum, were mixed
with nuclear proteins for 4 h at 4 °C prior addition of the
probe.
Glutathione S-Transferase Fusion Protein Interaction
Assay
GST and GST fusion proteins were expressed in
Escherichia coli BL-21(DE3). Overnight cultures of bacteria
that were newly transformed with the plasmids were diluted with 20 volumes of medium, cultured for several hours to an optical density at
600 nm of 0.6, and induced with 0.4 mM isopropyl
-D-thiogalactopyranoside at 37 °C for 3 h.
Bacteria from 125 ml of culture were harvested and resuspended in 1.5 ml of NETN (20 mM Tris pH 8, 100 mM NaCl, 1 mM EDTA, 0.5% Nonidet P-40, 10 µg of leupeptin/ml, 10 µg of pepstatin/ml, 10 µg of aprotinin/ml, 1 mM
phenylmethylsulfonyl fluoride). The lysates were sonicated and after
centrifugation, the supernatants were mixed with glutathione-Sepharose
4B beads (40 µl, Pharmacia) at 4 °C overnight in NETN buffer. The
35S-labeled input Sp1 protein was prepared by in
vitro translation using the TNT T7 system (Promega) according to
the manufacturer's suggestions. The coated beads (40 µl) were washed
with NETN and further incubated for 2 h at 4 °C with 15 µl of
the total in vitro translated protein reaction mixture in a
final volume of 300 µl of binding buffer (50 mM Tris-Cl,
pH 7.6, 50 mM NaCl, 0.02% Tween 20, 0.02% bovine serum
albumin) containing antiproteases as in NETN. After extensive washing
with washing buffer (50 mM Tris-Cl, pH 7.6, 150 mM NaCl, 0.02% Tween 20) containing the antiproteases, the
bound proteins were dissociated by boiling for 5 min in Laemmli sample
buffer and subjected to SDS-PAGE.
Association of Proteins in Vitro
GST and GST fusion
proteins were expressed from a 2-ml bacterial culture and mixed with
glutathione-Sepharose 4B beads (Pharmacia) at 4 °C overnight in NETN
buffer. The coated beads (30 µl) were washed with NETN and further
incubated for 2 h at 4 °C with pure Sp1 (2 footprint units,
Promega) in 300 µl of binding buffer. After extensive washing with
washing buffer, the bound proteins were dissociated with 20 mM glutathione, 50 mM Tris, pH 8 (15 µl), and
subjected to EMSA in the presence of labeled Sp1 oligonucleotide.
Immunoprecipitations
Protein extracts were prepared
according to two distinct methods: cell lysates were prepared from
cells plated in a 10-cm dish according to the reported procedure (30)
or nuclear proteins were isolated as described previously (25). Cell
lysates or nuclear proteins were resuspended in 400 µl of TNE (50 mM Tris, pH 8.0, 1% Nonidet, 2 mM EDTA, and a
mixture of protease inhibitors), mixed with protein A-agarose beads (20 µl) and gently shaken for 1 h at 4 °C. The suspension was
briefly centrifuged and the supernatant was mixed with 3 µl of
anti-Sp1 antibodies or preimmune serum. After overnight incubation at
4 °C, protein A-agarose (30 µl) was added and mixed for 2 h.
After extensive washing of the beads with TNE, 15 µl of beads were
mixed with 5 µl of buffer Z (20 mM HEPES, pH 7.9, 1 mM MgCl2, 60 mM KCl, 0.5 mM EDTA, 1 mM dithiothreitol, 10% glycerol)
and either subjected to EMSA in the presence of the 3L oligonucleotide
probe, or processed for Western blotting with COUP-TF antibodies, as
described previously (25).
RESULTS
COUP-TF Present in Microglial Cells Binds to the Nuclear Receptor
Responsive Element of the LTR of HIV-1 LAI and Not HIV-1 JR-FL
We
have previously shown that within different brain cell lines
(oligodendroglioma, astrocytoma, and neuroblastoma) COUP-TFs are the
major protein species which interact with the NRRE located in the
352/ 320 modulatory region of the LTR (25) (Fig.
1). To examine whether COUP-TFs are also
present in human microglial cells and interact with the NRRE, gel
mobility supershift assays were performed with nuclear proteins
isolated from microglial cells, in the presence of COUP-TF antibodies.
With the 3L oligonucleotide probe, corresponding to the NRRE sequence
present in the lymphotropic HIV-1 LAI isolate, the results show that
the COUP-TFs species do form the majority of the DNA-protein complexes
C1, C3, and C3 (Fig. 2, lanes
3-5). This confirms that within human microglial cells, like in
other brain cells, COUP-TFs are the major nuclear proteins interacting
with the NRRE. When we used as a probe oligonucleotide 3N corresponding
to the NRRE site present in the LTR of the CNS-derived macrophage-tropic HIV-1 JR-FL, the formation of complexes C1, C3, and
C3 was prevented (lane 2). This clearly indicates that COUP-TFs present in nuclear extracts are unable to interact with the
mutant NRRE sequence present in the JR-FL LTR.
Fig. 1.
The HIV-1 LTR and localization of some
binding sites. NRRE, NF- B, Sp1, and TATA elements are
indicated.
[View Larger Version of this Image (8K GIF file)]
Fig. 2.
COUP-TF binding activity to the 352/ 324
LTR site of HIV-1 in human microglial cells. Nuclear protein
extracts (5 µg) were assayed by gel retardation assay with 1 ng of
32P-end-labeled 3L or 3N oligonucleotide probe. The
DNA-protein complexes C1, C3, C3 , C4 are named as described previously
(26). For supershift assays, 1 µl of COUP-TF antiserum (lane
COUP) or nonimmune serum (lane NIS) was mixed with
nuclear proteins 4 h prior addition of the 3L probe. The sequence
of the 3L and 3N synthetic oligonucleotides is indicated. Open
squares correspond to a mutant nucleotide.
[View Larger Version of this Image (35K GIF file)]
COUP-TF Stimulates LTR-directed HIV-1 Gene Transcription in
Microglial Cells via the Proximal LTR Region
To examine the role
of COUP-TF on HIV-1 gene transcription in microglial cells,
transfection experiments were performed with a LTR-CAT reporter vector,
containing the CAT gene under the control of the HIV-1 LTR
region. With construct 1 containing the LTR of the HIV-1 LAI strain
(Fig. 3), COUP-TF acts as a
transcriptional activator of the HIV-1 genome, since in transfection
experiments, LTR-driven CAT expression was stimulated 4.8-fold. It was
interesting to compare this result with that of construct 2 containing
the LTR region from the HIV-1 JR-FL, since as shown above (Fig. 2), the
NRRE site of the JR-FL LTR contains mutations which prevent the binding
of COUP-TF. Surprisingly, CAT expression was still stimulated 3.8-fold,
indicating that the mutation of the NRRE does not prevent
COUP-TF-induced activation.
Fig. 3.
Functional effects of COUP-TF on HIV-1
LTR-driven transcription in human microglial cells. Left panel,
LTR-CAT constructs used in transient expression assays. The LTR
region of the LAI and JR-FL HIV-1 strains was 5 -end deleted.
Right panel, relative CAT activities in microglial cells
transfected with the LTR-CAT constructs, either alone or in the
presence of the COUP-TF expression vector. CAT activities are expressed
relative to that of construct 1 taken as 1. Numbers in
brackets indicate the fold stimulation induced by
COUP-TF.
[View Larger Version of this Image (19K GIF file)]
The LTR sequences responsible for the COUP-TF-induced activation were
delineated by transfecting a series of LTR-CAT vectors containing
5 -deletions of the LTR region (Fig. 3). Although the basal level of
transcription dropped to 10% with 89/+80 LTR-CAT and 68/+80
LTR-CAT, compared with the full-length vector, COUP-TF was still able
to exert a respective 6.1- and 6.8-fold transcriptional stimulation.
The COUP-TF-induced activation was abolished only by the removal of the
two binding sites of the Sp1 transcription factor between position 68
and 40. Moreover, the 68/+29 LTR region was still able to mediate a
5.6-fold COUP-TF-induced stimulation, allowing us to localize the
COUP-TF response element within the minimal 68/+29 region. This
result indicates that the action of COUP-TF on the LTR is not mediated
via the NRRE site, but rather via the minimal 68/+29 LTR site. It
further suggests that COUP-TF needs the presence of the two Sp1
elements located within the 68/ 40 region and is unable to function
via interactions with the TATA element alone.
To test whether COUP-TF could activate any promoter composed of Sp1
sites and a TATA element, we performed transfection experiments with
the pUC-CAT2 vector, containing the simian virus 40 (SV40) early
promoter formed by six Sp1 sites and a TATA box. In microglial cells,
COUP-TF activated the SV40 promoter only 2-fold. In contrast, in HeLa
cells, COUP-TF was able to stimulate transcription about 10-fold
(results not shown). These findings suggest that the action of COUP-TF,
via Sp1 sites, is dependent both on the promoter context and the cell
type.
COUP-TF Does Not Bind Directly to the T3R Element of the HIV-1
LTR
It has been reported that the thyroid hormone receptor T3R,
another member of the nuclear receptor superfamily interacts directly with the T3R element (T3RE) overlapping the Sp1 sites within the 74/ 50 HIV-1 LTR (31). Therefore the possibility existed that COUP-TF might also bind directly to this region. To test this hypothesis, we carried out gel retardation experiments, using as a
probe oligonucleotide T3RE containing the three Sp1-binding sites (Fig.
4A). With nuclear proteins
isolated from microglial cells, four DNA-protein complexes a to d were
detected. The formation of complexes a to c was abolished with a
50-fold molar excess of homologous oligonucleotide T3RE, showing the
specificity of these interactions (lanes 1 and
2). The minor complex d appeared less specific. In contrast,
oligonucleotide 3L which binds COUP-TF, failed to compete for the
formation of all four complexes (lane 3). This result
already indicates that COUP-TF is not present within the complexes
formed with the T3RE sequence.
Fig. 4.
Sp1 and Sp3 present in human microglial cells
interact with the 83/ 45 region of the HIV-1 LTR. A, gel
retardation assays with the T3RE oligonucleotide probe and 10 µg of
nuclear extracts from microglial cells. Competition assays were
performed with a 50-fold molar excess of unlabeled T3RE or 3L
oligonucleotide. Supershift assays were carried out with antibodies
directed against proteins indicated on top or with nonimmune
serum (NIS). The sequence of the T3RE oligonucleotide and
the three Sp1 sites are indicated. B, immunoblot detection
of Sp1 and Sp3 in microglial cells. Nuclear proteins (10 µg) from
microglial cells were fractionated on a SDS-polyacrylamide gel, blotted
on nitrocellulose filter, and incubated with antibodies directed
against Sp1 (lane 1) or Sp3 (lane 2).
[View Larger Version of this Image (71K GIF file)]
To identify the nature of the T3RE-binding proteins present in
microglial cells, supershift assays were performed with antibodies directed against transcription factors previously described to bind to
this site. As expected, antibodies directed against Sp1 were able to
supershift complex b (Fig. 4, lanes 6). Antibodies directed
against Sp3 were able to prevent the formation of complexes a and c
(lane 4), and a mixture of both anti-Sp1 and anti-Sp3 antibodies prevented the formation of complexes a, b, and c (lane 5). These results clearly show that only Sp1 and Sp3 proteins present in microglial cells interact directly with the T3RE sequence. Surprisingly antibodies directed against the thyroid hormone receptor T3R did not alter the pattern of the complexes (lane 7),
suggesting that either T3R is not expressed in microglial cells or has
a lower binding affinity compared with Sp1 and Sp3. As a control, the
complexes were unaffected in the presence of nonimmune serum (lane 8). A closely related pattern was already described
with proteins from CV1, HeLa, and Jurkat cells (32, 33). The generation of the two a and c Sp3-specific complexes coincides with the appearance of at least two bands in the 80- and 55-kDa range in Western blots with
anti-Sp3 antibodies (Fig. 4B).
Regulation of HIV-1 LAI and JR-FL LTR-directed Gene Transcription
by COUP-TF, Sp1, and Sp3
Since COUP-TF stimulates transcriptional
activity of the LTR 4-5-fold, by acting on the same response element
as Sp1 and Sp3, we investigated how HIV-1 gene transcription is
modulated by the individual action of each factor as well as by the
combination of the various transcription factors (Fig.
5). Cotransfection experiments with the
LTR(JR-FL)-CAT vector showed that overexpression of Sp1 resulted in a
4-fold transcriptional stimulation. Interestingly, overexpression of
both COUP-TF (0.2 pmol) and Sp1 (0.5 pmol) led to a 13-fold increase in
CAT activity. This indicates that both proteins are able to function in
a synergistic manner. Sp3 has been described as a bifunctional
transcription regulator of eukaryotic gene expression (34) and as a
repressor of HIV-1 gene transcription in HeLa and Drosophila
cells (32). In microglial cells, Sp3 functions also as a potent
repressor of LTR-directed HIV-1 gene transcription, since the remaining
CAT activity was 30% with 0.2 or 0.5 pmol of expression vector.
Moreover overexpression of Sp3 resulted in a 2-fold inhibition of both
the Sp1- or COUP-TF-mediated stimulation (Fig. 5).
Fig. 5.
Regulation of HIV-1 gene transcription by
COUP-TF, Sp1, and Sp3 in human microglial cells. Transient
expression experiments were performed by cotransfecting the
HIV-1(JR-FL)-CAT or 68/+80 LTR-CAT reporter vectors (1 pmol) with
vectors expressing COUP-TF (0.2 pmol), Sp1 (0.5 pmol), or Sp3 (0.5 pmol) as indicated. Histograms show the CAT activities expressed
relative to the value obtained with the LTR-CAT reporter vector. Values
correspond to an average of at least three independent experiments done
in duplicate. The standard deviation did not exceed 20%.
[View Larger Version of this Image (29K GIF file)]
It was of interest to examine the effect of the activators COUP-TF and
Sp1 on the transcriptional activity mediated by the 68/+80 proximal
LTR region. In this region, the LTR sequence of the LAI and JR-FL
isolates are similar. Interestingly, the proximal promoter mediated a
6.0-fold COUP-TF-induced stimulation, compared with the lower 3.8-fold
stimulation mediated by the entire LTR region. Similarly, Sp1
transactivated the proximal promoter 4.2- and 14-fold, after
transfection of 0.2 and 0.5 pmol of Sp1 vector, respectively. Moreover,
the combined action of COUP-TF (0.2 pmol) and Sp1 (0.2 or 0.5 pmol)
resulted in a synergistic effect, since transcription was stimulated
15- and 27-fold, respectively.
The COUP-TF protein can be divided into distinct functional domains,
such as a N-terminal DNA-binding domain and a C-terminal dimerization
domain. To identify which part of the COUP-TF protein is involved in
transactivation, we cotransfected LTR(JR-FL)-CAT with vectors
expressing 3 -deletion mutants of COUP-TF (Fig.
6). Results demonstrate that the
C-terminal region is required for transactivation; construct
pRSV-COUPdel148 containing only the DNA-binding domain was unable to
significantly activate the HIV-1 promoter.
Fig. 6.
Transcriptional activity of COUP-TF deletion
mutants. Microglial cells were co-transfected with LTR(JR-FL)-CAT
and vectors expressing deletion mutants of COUP-TF. Cell extracts were
prepared 48 h after transfection and CAT activities were determined. Activities are expressed as fold stimulation over the
activity of LTR-CAT cotransfected with the parental pRc/RSV vector.
[View Larger Version of this Image (11K GIF file)]
COUP-TF and Sp1 Are Able to Interact in Vitro and in the
Cell
To decipher the mechanism whereby COUP-TF and Sp1 mediate a
transcriptional synergistic activation, we first tested whether COUP-TF
and Sp1 interact in vitro. We generated a GST-COUP fusion protein (Fig. 7A) and analyzed
the ability of in vitro translated Sp1 in the presence of
[35S]methionine to interact with GST-COUP-1. SDS-PAGE
analysis of proteins retained by glutathionine-Sepharose shows that
35S-labeled Sp1 associates with GST-COUP-1 (Fig. 7B,
lane 4). This association is specific, since Sp1 was bound to
GST-COUP-1 but not to GST alone (lane 3). Three labeled
bands are detected on SDS-PAGE, which correspond to the three bands of
approximately 100, 55, and 40 kDa, detected with the input protein on
Western blots (lane 1).
Fig. 7.
The DNA-binding domain of COUP-TF interacts
with Sp1 in vitro. A, schematic representation
of GST-COUP-TF constructs. Plasmids expressing deletion mutants of
COUP-TF were constructed as described under "Materials and
Methods." B, visualization of the interaction between
COUP-TF and Sp1. The Sp1 protein was translated in wheat germ lysates
(Promega) and analyzed by Western blot with anti-Sp1 antibodies
(lane 1). 35S-Labeled Sp1 protein (lane
2) translated in wheat germ lysate, was incubated with bacterially
expressed GST or GST-COUP (constructs 1 to 3) immobilized on
glutathione-Sepharose beads. After extensive washing, the bound
proteins were eluted and analyzed by SDS-PAGE followed by
autoradiography (lanes 3-6). C, analysis of
association of Sp1 with GST-COUP-TF by gel mobility shift assays. Sp1
protein (2 footprint units, Promega) was incubated with bacterially
expressed GST or GST-COUP-1, -2, -3 proteins immobilized on
glutathione-Sepharose beads. After extensive washing, the bound
proteins were eluted and analyzed by gel mobility shift assays. Binding
assays were performed with 1 ng of labeled Sp1 probe either with Sp1
protein (2 footprint units, Promega, lane 1) or with
bacterially expressed GST or GST-COUP fusion proteins incubated in the
presence (lanes 2-5) or absence of Sp1 (lanes
6-8), as described under "Materials and Methods." DNA-protein
complexes were separated on a 4% polyacrylamide gel.
[View Larger Version of this Image (30K GIF file)]
To localize the domain of COUP-TF that mediates interaction with Sp1,
we constructed GST-COUP expression vectors containing serial 3
deletions of COUP-TF (Fig. 7A). Results from GST pull down
experiments show that GST-COUP-2 and even GST-COUP-3 encoding residues
49 to 148 of COUP-TF were still able to mediate association with Sp1
(lanes 5 and 6), confirming that the N-terminal
part of COUP-TF containing the DNA-binding domain is sufficient for interaction with Sp1 in vitro.
We further investigated the interactions between COUP-TF, Sp1, and the
Sp1 DNA-binding site. Pure Sp1 protein was incubated with
glutathione-Sepharose beads retaining bacterially expressed GST-COUP
protein. After extensive washings, the bound proteins were eluted and
analyzed by gel shift assays with the Sp1 oligonucleotide probe (Fig.
7C). Addition of pure Sp1 protein in the binding reaction led to the formation of a retarded complex (lane 1). As
expected GST-COUP fusion proteins alone were unable to bind to the Sp1 probe (lanes 6-8). Interestingly, addition in the binding
reaction of GST-COUP-1 preincubated with Sp1 resulted in a supershift
of the Sp1-DNA complex (lane 2). This result demonstrates
that COUP-TF is able to physically associate with Sp1 bound to its
DNA-binding site. Both truncated GST-COUP-2 and GST-COUP-3 proteins
were still able to supershift the Sp1-DNA complex (lanes 3 and 4), indicating that the N-terminal sequences containing
the DNA-binding domain of COUP-TF are sufficient for binding with Sp1.
As a control, a barely detectable band was formed when Sp1 was
incubated with GST (lane 5), showing the specificity of the
interaction between GST-COUP and Sp1.
These in vitro results were confirmed in vivo by
immunoprecipitation experiments with extracts from microglial cells
(Fig. 8). The presence of COUP-TFs
species was detected in gel shift assays with the 3L probe (Fig.
8A). Antibodies directed against Sp1 (lanes 4 and
7), but not non-immune serum (lane 6), were able to immunoprecipitate endogeneous COUP-TF species. As a control, in the
absence of antiserum, no complex was detected (lane 3). The
amount of immunoprecipitated proteins was dependent on the method used
for protein extraction, as described under "Materials and Methods":
when we subjected cell lysates to immunoprecipitation, complex C1 was
predominant (lane 4); when we used nuclear protein extracts,
complexes C1, C3, C3 , and C4 were detected (lane 7). As
expected, complexes C1, C3, and C3 were specifically competed with an
excess of 3L competitor (lane 5) and their formation was prevented in the presence of COUP-TF antibodies (lane 8).
Surprisingly, protein forming complex C4 was also partially
immunoprecipitated, with anti-Sp1, but not with nonimmune serum, which
may suggest an interaction of this protein with either Sp1 or COUP-TF.
In addition, the ability of anti-Sp1 antibodies to coimmunoprecipitate the COUP-TF protein was visualized by Western blotting with COUP-TF antibodies (Fig. 8B).
Fig. 8.
Association of COUP-TF and Sp1 in
vivo. A, cell lysates (lanes 1-6) or
nuclear protein extracts (lanes 7 and 8) were prepared and immunoprecipitated in the presence of anti-Sp1 antibodies or nonimmune serum (NIS). Immunoprecipitates were assayed
for the presence of COUP-TFs by EMSA performed with the labeled 3L probe, in the absence or presence of an excess of unlabeled 3L competitor, or in the presence of COUP-TF antibodies (lane
8). As a control, EMSA was performed on cell lysates not subjected to immunoprecipitation (lanes 1 and 2).
B, the ability of anti-Sp1 to coimmunoprecipitate COUP-TF
was visualized by Western blotting with COUP-TF antibodies (lane
2). As a control, lane 1 corresponds to
nonimmunoprecipitated nuclear proteins. The arrow points to the 45-kDa COUP-TF protein.
[View Larger Version of this Image (37K GIF file)]
DISCUSSION
In this report we have investigated the regulation of HIV-1 gene
transcription in human microglial cells, which represent the primary
target of HIV-1 infection in the central nervous system. Since we have
previously shown that the orphan nuclear receptor COUP-TF is expressed
in brain cells and leads to a transcriptional stimulation of the HIV-1
genome in oligodendroglioma and neuronal cells (25), we have focused
our studies on the regulation of HIV-1 gene transcription by COUP-TF in
microglial cells. It is now well established that COUP-TF is able to
exert both positive and negative effects on gene expression, depending
upon the promoter and the cell contexts (29, 35-38). We show here that
COUP-TF proteins are present in human microglial cells and interact
directly with the NRRE, spanning the 356/ 320 LTR region of the
lymphotropic HIV-1 LAI isolate, but are unable to bind to the mutant
NRRE present in the macrophage-tropic HIV-1 JR-FL isolate.
Interestingly, our transient expression data reveal that COUP-TF/Ear3
is able to activate HIV-1 LTR-driven transcription in microglial cells,
independently of the NRRE sequence. This shows that COUP-TF is able to
transactivate the LTR from the lymphotropic LAI and the
macrophage-tropic JR-FL isolates.
We have already reported that distinct cell-type specific and
sequence-dependent mechanisms govern COUP-TF-induced
stimulation. In oligodendrocytes this transcription factor stimulates
HIV-1 gene transcription, either by direct interactions with its NRRE target site or also, depending on the LTR sequence, by cross-coupling interactions with downstream-located proteins. In neuronal SK-N-MC cells, the transcriptional stimulation induced by COUP-TF in the presence of dopamine is mediated by the minimal 68/+29 LTR region (25). Similarly the NRRE site in the JR-CSF LTR is not indispensable for the stimulation induced by the retinoic acid receptor, since the
retinoid action appears to be mediated by downstream-located elements,
such as the 247/ 222 AP-1 region and, to a lesser extent, the
NF- B region (26).
We show here that the minimal 68/+29 LTR region, containing two
Sp1-binding sites, is sufficient for COUP-TF-mediated stimulation. Our
cotransfection and in vitro experiments demonstrate the
ability of COUP-TF to transactivate the LTR indirectly via the Sp1
sites, by direct interaction with the Sp1 protein. We present evidence for a direct association between the N-terminal part of COUP-TF, containing the DNA-binding domain, with Sp1. Our data show that COUP-TF
can interact with Sp1 both in vitro and in microglial cells.
This association leads to a functional cooperation between the two
proteins, which is detected with the full-length LTR as well as the
68/+80 LTR region. Moreover we show that the C-terminal domain of
COUP-TF is involved in the transcriptional activation.
Previous studies have already described that the action of COUP-TFs can
be mediated not only by direct interaction with their DNA-binding site,
but also by protein-protein interaction. COUP-TFI/Ear3 and
ARP-1/COUP-TFII are able to directly target components of the basal
transcription machinery, such as the basal transcription factor TFIIB
(39, 40). TFIIB recognizes and associates with COUP-TF and two other
members of the steroid hormone receptor family, via their activation
domain (39). In contrast, our findings reveal that COUP-TF associates
with Sp1 via its N-terminal part, containing the DNA-binding domain. A
direct interaction between COUP-TF and the transcription factors Oct1
and Oct2 has also been demonstrated in the regulation of the vHNFI
promoter (30).
It has been well established that the Sp1 transcription factor (41)
plays an essential role in the regulation of basal transcription as
well as in Tat-mediated transactivation of the HIV-1 LTR (42-44). Recent reports describe that Sp1 is critical for in vivo
transcriptional regulation of HIV, through its interaction with other
DNA-binding proteins. A cooperative interaction between Sp1 and
NF- B, bound to the two adjacent binding sites, is required for
optimal HIV-1 enhancer activation and inducible HIV-1 gene expression
(32, 45, 46). A physical interaction between Sp1 and the p53
tumor-suppressor gene has been described in the tumor necrosis
factor-induced transcriptional activation of the HIV-1 LTR (47).
Moreover in vitro and in vivo data suggest a
direct interaction between Sp1 and Tat during transactivation (48,
49).
Here our findings reveal a novel direct association between two zinc
finger proteins, Sp1 and COUP-TF, which leads to enhanced transcriptional activation of the HIV-1 genome. These data suggest a
more general model for gene activation by the orphan receptor COUP-TF
or steroid/thyroid/retinoid receptors, in the presence of Sp1-binding
sites. As shown here, Sp1 bound to its DNA-binding site is able to
associate directly with the N-terminal DNA-binding domain of the
nuclear receptor. It is well known that the adjacent TATA element binds
the general transcription factor TFIID, which directly interacts with
TFIIB, which itself is able to bind COUP-TF. In such a situation, the
nuclear receptor may function as an adaptor protein, bringing together
Sp1 and TFIIB, thereby enhancing communication between the general
transcription machinery and Sp1. Alternatively, COUP-TF may bring
together Sp1 and a cell type-specific nuclear factor, leading to
various levels of activation induced by COUP-TF in different cell
types. The precise mechanisms which account for our observations in the
case of HIV-1 and SV40 gene transcription need to be further
investigated.
The Sp1 multigene family contains three closely related members Sp1,
Sp3, and Sp4 which recognize the GC box and the GT motif (33). While
Sp1 and Sp4 function as transcriptional activators, Sp3 is a
bifunctional transcription regulator, whose activity is dependent upon
the promoter and the cellular contexts (33, 34). Recent reports have
established that different members of the Sp1 family exert opposite
transcriptional regulation of the HIV LTR. While Sp1 and Sp4 stimulate
transcription of the LTR, Sp3 markedly represses the HIV promoter
activity in HeLa and Drosophila SL2 cells.
Sp3-dependent repression is dependent on the presence of
the DNA-binding domain, indicating that repression occurs through
interference with Sp1 binding to the GC motifs (32). Our data confirm
that Sp1 and Sp3 are present in microglial cells, and exert an
antagonist action on LTR-driven transcription. Moreover they show that
Sp3 is able to mediate transcriptional repression not only of the Sp1
action, but also of the COUP-TF action exerted via Sp1.
Only a limited number of studies have been devoted to HIV-1 gene
transcription in macrophages and microglial cells. A differential role
of LTR elements for the regulation of basal and Tat-mediated transcription of HIV-1 has been reported in stimulated and unstimulated primary human macrophages (50). Our findings establish the essential role of the orphan nuclear receptor COUP-TF as a transcriptional activator of LTR-directed HIV-1 gene expression in microglial cells.
They further reveal a novel mechanism of HIV-1 gene transactivation by
direct association of COUP-TF with Sp1, thus enhancing transcription via the minimal LTR region. Our present and previous studies (25) reveal the remarkable diverse mechanisms by which COUP-TF regulates gene transcription of distinct HIV-1 strains and in different brain
cells.
FOOTNOTES
*
This work was supported in part by the Institut National de
la Santé et de la Recherche Médicale (U338), the Agence
Nationale des Recherches sur le SIDA, the Fondation pour la Recherche
Medicale (FRM), the association "Le Cercle d'Emeraude."The costs of publication of this
article were defrayed in part by the
payment of page charges. The article
must therefore be hereby marked
"advertisement" in accordance with 18 U.S.C. Section
1734 solely to indicate this fact.
Supported by the association "Ensemble contre le SIDA" and
Fondation pour la Recherche Medicale (Sidaction).
§
To whom all correspondence should be addressed. Tel.:
33-388-45-67-18; Fax: 33-388-60-08-06.
1
The abbreviations used are: HIV-1, human
immunodeficiency virus type 1; CNS, central nervous system; LTR, long
terminal repeat; COUP-TF, chicken ovalbumin upstream promoter
transcription factor; NRRE, nuclear receptor responsive element; CAT,
chloramphenicol acetyltransferase; RSV, Rous sarcoma virus; EMSA,
electrophoretic mobility shift assay; GST, glutathione
S-transferase; PAGE, polyacrylamide gel electrophoresis;
TFII, transcription factor II.
ACKNOWLEDGEMENTS
We thank N. Israël and J. Clements for
providing the vectors containing the LAI and JR-FL LTR, respectively.
We are grateful to R. Tjian and G. Suske for providing the Sp1 and Sp3
expression vectors, respectively, and M. J. Tsai for providing the
COUP-TF antibodies.
REFERENCES
-
Fauci, A. S.
(1988)
Science
239,
617-622
[Abstract/Free Full Text]
-
Portegies, P., and Brew, B. J. (1991) AIDS 5, Suppl. 2, S211-S217
-
Perry, V. H., Lawson, L. J., and Reid, D. M.
(1994)
J. Leukocyte Biol.
56,
399-406
[Abstract]
-
Wiley, C. A., Schrier, R. D., Nelson, J. A., Lampert, P. W., and Oldstone, M. B.
(1986)
Proc. Natl. Acad. Sci. U. S. A.
83,
7089-7093
[Abstract/Free Full Text]
-
Price, R. W., Brew, B., Sidtis, J., Rosenblum, M., Scheck, A. C., and Cleary, P.
(1988)
Science
239,
586-592
[Abstract/Free Full Text]
-
Watkins, B. A., Dorn, H. H., Kelly, W. B., Armstrong, R. C., Potts, B. J., Michaels, F., Kufta, C. V., and Dubois-Dalcq, M.
(1990)
Science
249,
549-553
[Abstract/Free Full Text]
-
Peudenier, S., Hery, C., Montagnier, L., and Tardieu, M.
(1991)
Annu. Neurol.
29,
152-161
[CrossRef][Medline]
[Order article via Infotrieve]
-
Hatch, W. C., Pousada, E., Rashbaum, W. K., and Lyman, W. D.
(1994)
AIDS Res. Hum. Retroviruses
10,
1597-1607
[Medline]
[Order article via Infotrieve]
-
Nuovo, G. J., Gallery, F., MacConnell, P., and Braun, A.
(1994)
Am. J. Pathol.
144,
659-666
[Abstract]
-
Albright, A. V., Strizki, J., Harouse, J. M., Lavi, E., O'Connor, M., and Gonzalez-Scarano, F.
(1996)
Virology
217,
211-219
[CrossRef][Medline]
[Order article via Infotrieve]
-
Stritzki, J. M., Albright, A. V., Sheng, H., O'Connor, M., Perrin, L., and Gonzalez-Scarano, F.
(1996)
J. Virol.
70,
7654-7662
[Abstract]
-
He, J., Chen, Y., Farzan, M., Choe, H., Ohagen, A., Gartner, S., Busciglio, J., Yang, X., Hofman, W., Newman, W., Mackay, C. R., Sodroski, J., and Gabuzda, D.
(1997)
Nature
385,
645-649
[CrossRef][Medline]
[Order article via Infotrieve]
-
Garcia, J. A., and Gaynor, R. B.
(1994)
Prog. Nucleic Acid Res. Mol. Biol.
49,
157-196
[Medline]
[Order article via Infotrieve]
-
Kingsman, S. M., and Kingsman, A. J.
(1996)
Eur. J. Biochem.
240,
491-507
[Medline]
[Order article via Infotrieve]
-
Koyanagi, Y., Miles, S., Mitsuyasu, R. T., Merrill, J. E., Vinters, H. V., and Chen, I. S. Y.
(1987)
Science
236,
819-822
[Abstract/Free Full Text]
-
Corboy, J. R., Busy, J. M., Zink, M. C., and Clements, J. E.
(1992)
Science
258,
1804-1808
[Abstract/Free Full Text]
-
Busy, J. M., Lindstrom, L. M., Zink, M. C., and Clements, J. E.
(1995)
Virology
210,
361-371
[CrossRef][Medline]
[Order article via Infotrieve]
-
Kurth, J., Busy, J. M., Lindstrom, L., and Clements, J. E.
(1996)
J. Virol.
70,
7686-7694
[Abstract]
-
Rattner, A., Korner, M., Walker, M. D., and Citri, Y.
(1993)
EMBO J.
12,
4261-4267
[Medline]
[Order article via Infotrieve]
-
Kaltschmidt, C., Kaltschmidt, B., Neumann, H., Wekerle, H., and Baeuerle, P. A.
(1994)
Mol. Cell. Biol.
14,
3981-3992
[Abstract/Free Full Text]
-
Taylor, J. P., and Khalili, K.
(1994)
Adv. Neuroimm.
4,
291-303
-
Wang, L.-H., Tsai, S. Y., Sagami, I., Tsai, M.-J., and O'Malley, B. W.
(1987)
J. Biol. Chem.
262,
16080-16086
[Abstract/Free Full Text]
-
Wang, L. H., Tsai, S. Y., Cook, R. G., Beattie, W. G., Tsai, M. J., and O'Malley, B. W.
(1989)
Nature
340,
163-166
[CrossRef][Medline]
[Order article via Infotrieve]
-
Miyajima, N. Y., Kadowaki, S.-I., Fukushige, S.-I., Shimizu, K., Semba, Y., Yamanashi, K.-I., Matsubara, K., Yoyoshima, K., and Yamamoto, T.
(1988)
Nucleic Acids Res.
16,
11057-11069
[Abstract/Free Full Text]
-
Sawaya, B. E., Rohr, O., Aunis, D., and Schaeffer, E.
(1996)
J. Biol. Chem.
271,
23572-23576
[Abstract/Free Full Text]
-
Sawaya, B. E., Rohr, O., Aunis, D., and Schaeffer, E.
(1996)
J. Biol. Chem.
271,
22895-22900
[Abstract/Free Full Text]
-
Janabi, N., Peudenier, S., Héron, B., Ng, K. H., and Tardieu, M.
(1995)
Neurosci. Lett.
195,
105-108
[CrossRef][Medline]
[Order article via Infotrieve]
-
Canonne-Hergaux, F., Aunis, D., and Schaeffer, E.
(1995)
J. Virol.
69,
6634-6642
[Abstract]
-
Schaeffer, E., Guillou, F., Part, D., and Zakin, M. M.
(1993)
J. Biol. Chem.
268,
23399-23408
[Abstract/Free Full Text]
-
Power, S. C., and Cereghini, S.
(1996)
Mol. Cell. Biol.
16,
778-791
[Abstract]
-
Rahman, A., Esmaili, A., and Saatcioglu, F.
(1995)
J. Biol. Chem.
270,
31059-31064
[Abstract/Free Full Text]
-
Majello, B., De Luca, P., Hagen, G., Suske, G., and Lania, L.
(1994)
Nucleic Acids Res.
22,
4914-1921
[Abstract/Free Full Text]
-
Hagen, G., Müller, S., Beato, M., and Suske, G.
(1994)
EMBO J.
13,
3843-3851
[Medline]
[Order article via Infotrieve]
-
Majello, B., De Luca, P., and Lania, L.
(1997)
J. Biol. Chem.
272,
4021-4026
[Abstract/Free Full Text]
-
Kimura, A., Nishiyori, A., Murakami, T., Tsukamoto, T., Hata, S., Osumi, T., Okamura, R., Mori, M., and Takiguchi, M.
(1993)
J. Biol. Chem.
268,
11125-11133
[Abstract/Free Full Text]
-
Kadowaki, Y., Toyoshima, K., and Yamamoto, T.
(1995)
Proc. Natl. Acad. Sci. U. S. A.
92,
4432-4436
[Abstract/Free Full Text]
-
Sawaya, B. E., and Schaeffer, E.
(1995)
Nucleic Acids Res.
23,
2206-2211
[Abstract/Free Full Text]
-
Leng, X., Cooney, A. J., Tsai, S. Y., and Tsai, M.-J.
(1996)
Mol. Cell. Biol.
16,
2332-2340
[Abstract]
-
Ing, N. H., Beckman, J. M., Tsai, S. Y., Tsai, M. J., and O'Malley, B. M.
(1992)
J. Biol. Chem.
267,
17617-17623
[Abstract/Free Full Text]
-
Malik, S., and Karathanasis, S.
(1995)
Nucleic Acids Res.
23,
1536-1543
[Abstract/Free Full Text]
-
Kadonaga, J. T., Carner, K. R., Masiarz, F. R., and Tjian, R.
(1987)
Cell
51,
1079-1090
[CrossRef][Medline]
[Order article via Infotrieve]
-
Jones, K. A., Kadonaga, J. T., Luciw, P. A., and Tjian, R.
(1986)
Science
232,
755-759
[Abstract/Free Full Text]
-
Sune, C., and Garcia-Blanco, M. A.
(1995)
J. Virol.
69,
6572-6576
[Abstract]
-
Harrich, D., Garcia, J., Wu, F., Mitsuyasu, R., Gonazalez, J., and Gaynor, R.
(1989)
J. Virol.
63,
2585-2591
[Abstract/Free Full Text]
-
Perkins, N. D., Edwards, N. L., Duckett, C. S., Agranoff, A. B., Schmid, R. M., and Nabel, G. J.
(1993)
EMBO J.
12,
3551-3558
[Medline]
[Order article via Infotrieve]
-
Li, Y., Mak, G., and Franza, B. R., Jr.
(1994)
J. Biol. Chem.
269,
30616-30619
[Abstract/Free Full Text]
-
Gualberto, A., and Baldwin, A. S., Jr.
(1995)
J. Biol. Chem.
270,
19680-19683
[Abstract/Free Full Text]
-
Kamine, J., and Chinnadurai, G.
(1992)
J. Virol.
66,
3932-3936
[Abstract/Free Full Text]
-
Jeang, K. T., Chun, R., Lin, N. H., Gatignol, A., Glabe, C. G., and Fan, H.
(1993)
J. Virol.
67,
6224-6233
[Abstract/Free Full Text]
-
Moses, A. V., Ibanez, C., Gaynor, R., Ghazal, P., and Nelson, J. A.
(1994)
J. Virol.
68,
298-307
[Abstract/Free Full Text]
Volume 272, Number 49,
Issue of December 5, 1997
pp. 31149-31155
©1997 by The American Society for Biochemistry and Molecular Biology, Inc.

CiteULike Complore Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
L.-j. Zhang, X. Liu, P. R. Gafken, C. Kioussi, and M. Leid
A Chicken Ovalbumin Upstream Promoter Transcription Factor I (COUP-TFI) Complex Represses Expression of the Gene Encoding Tumor Necrosis Factor {alpha}-induced Protein 8 (TNFAIP8)
J. Biol. Chem.,
March 6, 2009;
284(10):
6156 - 6168.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. J. Higgins, S. Liu, M. Abdelrahim, K. Yoon, K. Vanderlaag, W. Porter, R. P. Metz, and S. Safe
Vascular Endothelial Growth Factor Receptor-2 Expression Is Induced by 17{beta}-Estradiol in ZR-75 Breast Cancer Cells by Estrogen Receptor {alpha}/Sp Proteins
Endocrinology,
July 1, 2006;
147(7):
3285 - 3295.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
I. A. Maksakova and D. L. Mager
Transcriptional Regulation of Early Transposon Elements, an Active Family of Mouse Long Terminal Repeat Retrotransposons
J. Virol.,
November 15, 2005;
79(22):
13865 - 13874.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
V. Goffin, D. Demonte, C. Vanhulle, S. de Walque, Y. de Launoit, A. Burny, Y. Collette, and C. Van Lint
Transcription factor binding sites in the pol gene intragenic regulatory region of HIV-1 are important for virus infectivity
Nucleic Acids Res.,
August 1, 2005;
33(13):
4285 - 4310.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. Marban, L. Redel, S. Suzanne, C. Van Lint, D. Lecestre, S. Chasserot-Golaz, M. Leid, D. Aunis, E. Schaeffer, and O. Rohr
COUP-TF interacting protein 2 represses the initial phase of HIV-1 gene transcription in human microglial cells
Nucleic Acids Res.,
April 22, 2005;
33(7):
2318 - 2331.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. Kim, R. Barhoumi, R. Burghardt, and S. Safe
Analysis of Estrogen Receptor {alpha}-Sp1 Interactions in Breast Cancer Cells by Fluorescence Resonance Energy Transfer
Mol. Endocrinol.,
April 1, 2005;
19(4):
843 - 854.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. M. Miller, K. W. Jarosinski, and K. A. Schat
Positive and Negative Regulation of Chicken Anemia Virus Transcription
J. Virol.,
March 1, 2005;
79(5):
2859 - 2868.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. A. Carlson, G. Leisman, J. Limoges, G. D. Pohlman, M. Horiba, J. Buescher, H. E. Gendelman, and T. Ikezu
Molecular Characterization of a Putative Antiretroviral Transcriptional Factor, OTK18
J. Immunol.,
January 1, 2004;
172(1):
381 - 391.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
O. Rohr, C. Marban, D. Aunis, and E. Schaeffer
Regulation of HIV-1 gene transcription: from lymphocytes to microglial cells
J. Leukoc. Biol.,
November 1, 2003;
74(5):
736 - 749.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Y. Zhang and M. L. Dufau
Repression of the Luteinizing Hormone Receptor Gene Promoter by Cross Talk among EAR3/COUP-TFI, Sp1/Sp3, and TFIIB
Mol. Cell. Biol.,
October 1, 2003;
23(19):
6958 - 6972.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. Peng, H. He, J. Hay, and W. T. Ruyechan
Interaction between the Varicella Zoster Virus IE62 Major Transactivator and Cellular Transcription Factor Sp1
J. Biol. Chem.,
September 26, 2003;
278(39):
38068 - 38075.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
X. Liu, X. Huang, and C. D. Sigmund
Identification of a Nuclear Orphan Receptor (Ear2) as a Negative Regulator of Renin Gene Transcription
Circ. Res.,
May 16, 2003;
92(9):
1033 - 1040.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
O. Rohr, D. Lecestre, S. Chasserot-Golaz, C. Marban, D. Avram, D. Aunis, M. Leid, and E. Schaeffer
Recruitment of Tat to Heterochromatin Protein HP1 via Interaction with CTIP2 Inhibits Human Immunodeficiency Virus Type 1 Replication in Microglial Cells
J. Virol.,
May 1, 2003;
77(9):
5415 - 5427.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
I. Lacroix, C. Lipcey, J. Imbert, and B. Kahn-Perles
Sp1 Transcriptional Activity Is Up-regulated by Phosphatase 2A in Dividing T Lymphocytes
J. Biol. Chem.,
March 8, 2002;
277(11):
9598 - 9605.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. Liberati, M. R. Cera, P. Secco, C. Santoro, R. Mantovani, S. Ottolenghi, and A. Ronchi
Cooperation and Competition between the Binding of COUP-TFII and NF-Y on Human epsilon - and gamma -Globin Gene Promoters
J. Biol. Chem.,
November 2, 2001;
276(45):
41700 - 41709.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Y. Zhang and M. L. Dufau
EAR2 and EAR3/COUP-TFI Regulate Transcription of the Rat LH Receptor
Mol. Endocrinol.,
November 1, 2001;
15(11):
1891 - 1905.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. Shimada, Y. Suzuki, S.-J. Kim, P.-C. Wang, M. Matsumura, and S. Kojima
Transactivation via RAR/RXR-Sp1 Interaction: Characterization of Binding Between Sp1 and GC Box Motif
Mol. Endocrinol.,
October 1, 2001;
15(10):
1677 - 1692.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
I. Samudio, C. Vyhlidal, F. Wang, M. Stoner, I. Chen, M. Kladde, R. Barhoumi, R. Burghardt, and S. Safe
Transcriptional Activation of Deoxyribonucleic Acid Polymerase {{alpha}} Gene Expression in MCF-7 Cells by 17{{beta}}-Estradiol
Endocrinology,
March 1, 2001;
142(3):
1000 - 1008.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
F. Adam, T. Sourisseau, R. Métivier, Y. Le Page, C. Desbois, D. Michel, and G. Salbert
COUP-TFI (Chicken Ovalbumin Upstream Promoter-Transcription Factor I) Regulates Cell Migration and Axogenesis in Differentiating P19 Embryonal Carcinoma Cells
Mol. Endocrinol.,
December 1, 2000;
14(12):
1918 - 1933.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
W. Xie, R. Duan, I. Chen, I. Samudio, and S. Safe
Transcriptional Activation of Thymidylate Synthase by 17{beta}-Estradiol in MCF-7 Human Breast Cancer Cells
Endocrinology,
July 1, 2000;
141(7):
2439 - 2449.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
B. Lin, G.-q. Chen, D. Xiao, S. K. Kolluri, X. Cao, H. Su, and X.-k. Zhang
Orphan Receptor COUP-TF Is Required for Induction of Retinoic Acid Receptor beta , Growth Inhibition, and Apoptosis by Retinoic Acid in Cancer Cells
Mol. Cell. Biol.,
February 1, 2000;
20(3):
957 - 970.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
O. Rohr, C. Schwartz, C. Hery, D. Aunis, M. Tardieu, and E. Schaeffer
The Nuclear Receptor Chicken Ovalbumin Upstream Promoter Transcription Factor Interacts with HIV-1 Tat and Stimulates Viral Replication in Human Microglial Cells
J. Biol. Chem.,
January 28, 2000;
275(4):
2654 - 2660.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Y. Zhang and M. L. Dufau
Nuclear Orphan Receptors Regulate Transcription of the Gene for the Human Luteinizing Hormone Receptor
J. Biol. Chem.,
January 28, 2000;
275(4):
2763 - 2770.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. Schwartz, P. Catez, O. Rohr, D. Lecestre, D. Aunis, and E. Schaeffer
Functional Interactions between C/EBP, Sp1, and COUP-TF Regulate Human Immunodeficiency Virus Type 1 Gene Transcription in Human Brain Cells
J. Virol.,
January 1, 2000;
74(1):
65 - 73.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
D.-Q. Lou, M. Tannour, L. Selig, D. Thomas, A. Kahn, and M. Vasseur-Cognet
Chicken Ovalbumin Upstream Promoter-Transcription Factor II, a New Partner of the Glucose Response Element of the L-type Pyruvate Kinase Gene, Acts as an Inhibitor of the Glucose Response
J. Biol. Chem.,
October 1, 1999;
274(40):
28385 - 28394.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. Ahlgren, G. Suske, M. R. Waterman, and J. Lund
Role of Sp1 in cAMP-dependent Transcriptional Regulation of the Bovine CYP11A Gene
J. Biol. Chem.,
July 2, 1999;
274(27):
19422 - 19428.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Y. Suzuki, J. Shimada, K. Shudo, M. Matsumura, M. P. Crippa, and S. Kojima
Physical Interaction Between Retinoic Acid Receptor and Sp1: Mechanism for Induction of Urokinase by Retinoic Acid
Blood,
June 15, 1999;
93(12):
4264 - 4276.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. Pipaon, S. Y. Tsai, and M.-J. Tsai
COUP-TF Upregulates NGFI-A Gene Expression through an Sp1 Binding Site
Mol. Cell. Biol.,
April 1, 1999;
19(4):
2734 - 2745.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Stoner, F. Wang, M. Wormke, T. Nguyen, I. Samudio, C. Vyhlidal, D. Marme, G. Finkenzeller, and S. Safe
Inhibition of Vascular Endothelial Growth Factor Expression in HEC1A Endometrial Cancer Cells through Interactions of Estrogen Receptor alpha and Sp3 Proteins
J. Biol. Chem.,
July 21, 2000;
275(30):
22769 - 22779.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. Castro-Rivera, I. Samudio, and S. Safe
Estrogen Regulation of Cyclin D1 Gene Expression in ZR-75 Breast Cancer Cells Involves Multiple Enhancer Elements
J. Biol. Chem.,
August 10, 2001;
276(33):
30853 - 30861.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 1997 by the American Society for Biochemistry and Molecular Biology.
|
Advertisement
Advertisement
|